Kiora Pharmaceuticals
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
169 Saxony Rd Ste 212, Encinitas, Califo...Phone Number
(858) 224-9600Website
www.kiorapharma.comRevenue
-Stock Symbol
KPRXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Kiora Pharmaceuticals
Kiora Pharmaceuticals is viewed by third parties as a clinical-stage biotechnology company operating in the healthcare sector, with a specialized focus on developing therapies for retinal and eye-related diseases. It is primarily engaged in advancing small-molecule treatments designed to target underlying biological pathways that cause vision loss, particularly in conditions with limited existing treatment options. The company within the ophthalmic drug development space, where it conducts clinical trials and collaborates with partners to bring new therapies to market. Its pipeline includes investigational treatments aimed at restoring or preserving vision in diseases such as retinal degeneration and inflammation.Explore more
Kiora Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kiora Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kiora Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Kiora Pharmaceuticals
Click to see if Kiora Pharmaceuticals had a recent Job posting/layoffs
Check out if Kiora Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Kiora Pharmaceuticals has new funding data
Check if Kiora Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Kiora Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Kiora Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Kiora Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Kiora Pharmaceuticals
Compare insights from companies similar to Kiora Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kiora Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kiora Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kiora Pharmaceuticals.
Kiora Pharmaceuticals financials insights
Gather financial insights about Kiora Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$968K
2014
Debt
$994K
2015
Stock Offering
$4.1M
2020
Debt
$150K
2026
Stock/Share Issuance
$5M
Kiora Pharmaceuticals Tech Stack
A closer look at the technologies used by Kiora Pharmaceuticals
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Kiora Pharmaceuticals News & Media
Kiora Pharmaceuticals Raises $5 Million in Private Placement With $19 Million Warrant Upside
Kiora Pharmaceuticals completed a private placement with institutional investors, securing approximately $5.0 million in gross proceeds at closing and up to $19.0 million in potential future proceeds from warrant exercises. The financing includes 438,471 common shares, 1,527,711 pre-funded warrants…Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders
ENCINITAS, Calif. and WASHINGTON D.C., Oct. 30, 2025 /PRNewswire/ -- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and Global Genes today announced that Kiora has joined Global Genes' RARE-X Vision Consortium, a corporate-nonprofit partnership with a mission to promote and facilitate...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kiora Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Kiora Pharmaceuticals is viewed by third parties as a clinical-stage biotechnology company operating in the healthcare sector, with a specialized focus on developing therapies for retinal and eye-related diseases. It is primarily engaged in advancing small-molecule treatments designed to target underlying biological pathways that cause vision loss,... Read More
